Tilray Brands (NASDAQ:TLRY) Shares Down 8.7% – Should You Sell?

Tilray Brands, Inc. (NASDAQ:TLRY – Get Free Report)’s stock price traded down 8.7% during trading on Friday. The stock traded as low as $1.87 and last traded at $1.89. Approximately 7,807,036 shares changed hands during mid-day trading, an increase of 81% from the average daily volume of 4,312,612 shares. The stock had previously closed at $2.07.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on TLRY. Canaccord Genuity Group cut their price target on Tilray Brands from $4.50 to $4.00 and set a “hold” rating on the stock in a research note on Friday, October 9th. TD lowered their price objective on Tilray Brands from $4.70 to $4.50 and set a “buy” rating for the company in a research report on Monday, October 5th. Weiss Ratings lowered shares of Tilray Brands from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Friday, October 23rd. Zacks Research downgraded shares of Tilray Brands from a “hold” rating to a “strong sell” rating in a research report on Tuesday, September 29th. Finally, ATB Cormark Capital Markets lowered their price objective on shares of Tilray Brands from $8.00 to $6.00 and set a “hold” rating on the stock in a research report on Monday, September 21st. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, two have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $5.90.

Check Out Our Latest Stock Analysis on Tilray Brands

Tilray Brands Trading Down 8.7%

The stock has a market cap of $279.32 million, a price-to-earnings ratio of -1.35 and a beta of 2.04. The business’s fifty day simple moving average is $3.20 and its 200 day simple moving average is $5.05. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.88 and a quick ratio of 1.11.

Tilray Brands (NASDAQ:TLRY – Get Free Report) last announced its earnings results on Thursday, October 8th. The company reported ($0.02) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.16. Tilray Brands had a negative net margin of 16.91% and a negative return on equity of 10.39%. The firm had revenue of $257.15 million during the quarter, compared to analyst estimates of $266.26 million. On average, research analysts predict that Tilray Brands, Inc. will post -0.52 EPS for the current year.

Institutional Investors Weigh In On Tilray Brands

Hedge funds have recently bought and sold shares of the company. BlackRock Inc. bought a new stake in Tilray Brands in the 2nd quarter valued at $2,073,000. Swiss National Bank lifted its position in shares of Tilray Brands by 4.1% during the first quarter. Swiss National Bank now owns 230,503 shares of the company’s stock worth $1,491,000 after purchasing an additional 9,100 shares in the last quarter. Goldman Sachs Group Inc. increased its position in Tilray Brands by 68.5% in the third quarter. Goldman Sachs Group Inc. now owns 350,843 shares of the company’s stock worth $1,316,000 after purchasing an additional 142,569 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Tilray Brands by 6.1% in the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 208,229 shares of the company’s stock worth $935,000 after purchasing an additional 11,894 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in shares of Tilray Brands by 82.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 87,803 shares of the company’s stock valued at $568,000 after acquiring an additional 39,801 shares during the last quarter. 9.35% of the stock is currently owned by institutional investors.

Tilray Brands Company Profile

(Get Free Report)

Tilray Brands is a global cannabis and consumer packaged goods company. Its cannabis business produces and sells medical and adult-use products, including dried flower, oils, extracts and edibles, under brands such as Good Supply, Solei, Redecan and Broken Coast. The company serves customers in Canada, the United States and international markets. Its activities include medical cannabis distribution in countries where permitted, as well as cannabis and hemp-related products in North America, subject to local regulations.

See Also

Receive News & Ratings for Tilray Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray Brands and related companies with MarketBeat.com's FREE daily email newsletter.